| Mobile phone apps for inflammatory bowel disease self-management: a systematic assessment of content and tools D Con, P De Cruz JMIR mHealth and uHealth 4 (1), e4874, 2016 | 93 | 2016 |
| eHealth for inflammatory bowel disease self-management–the patient perspective D Con, B Jackson, K Gray, P De Cruz Scandinavian Journal of Gastroenterology 52 (9), 973-980, 2017 | 34 | 2017 |
| Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy D Con, B Andrew, S Nicolaides, DR van Langenberg, A Vasudevan Intestinal Research 20 (1), 101-113, 2022 | 30 | 2022 |
| Clinicians’ adherence to international guidelines in the clinical care of adults with inflammatory bowel disease BD Jackson, D Con, D Liew, P De Cruz Scandinavian Journal of Gastroenterology 52 (5), 536-542, 2017 | 25 | 2017 |
| Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease A Vasudevan, N Parthasarathy, D Con, S Nicolaides, R Apostolov, ... Alimentary Pharmacology & Therapeutics 52 (7), 1174-1184, 2020 | 22 | 2020 |
| Design considerations for an eHealth decision support tool in inflammatory bowel disease self‐management BD Jackson, D Con, P De Cruz Internal medicine journal 48 (6), 674-681, 2018 | 21 | 2018 |
| Faecal calprotectin delivers on convenience, cost reduction and clinical decision‐making in inflammatory bowel disease: a real‐world cohort study S Motaganahalli, L Beswick, D Con, DR van Langenberg Internal Medicine Journal 49 (1), 94-100, 2019 | 16 | 2019 |
| Examination of the relationship between disease activity and patient‐reported outcome measures in an inflammatory bowel disease cohort BD Jackson, D Con, A Gorelik, D Liew, S Knowles, P De Cruz Internal medicine journal 48 (10), 1234-1241, 2018 | 16 | 2018 |
| Thunderstorm asthma: revealing a hidden at‐risk population D Clayton‐Chubb, D Con, K Rangamuwa, D Taylor, F Thien, V Wadhwa Internal medicine journal 49 (1), 74-78, 2019 | 15 | 2019 |
| Comparison of 48‐week efficacy of tenofovir vs entecavir for patients with chronic hepatitis B: A network meta‐analysis D Con, T Goodwin, A Majeed, S Roberts, W Kemp Journal of viral hepatitis 28 (1), 40-50, 2021 | 14 | 2021 |
| Accuracy of gastrointestinal ultrasound and calprotectin in the assessment of inflammation and its location in patients with an ileoanal pouch ZS Ardalan, AB Friedman, D Con, S Chandran, D Gibson, A Pham, ... Journal of Crohn's and Colitis 16 (1), 79-90, 2022 | 13 | 2022 |
| Deep learning vs conventional learning algorithms for clinical prediction in Crohn's disease: A proof-of-concept study D Con, DR van Langenberg, A Vasudevan World Journal of Gastroenterology 27 (38), 6476, 2021 | 13 | 2021 |
| Acute medical stabilisation of adults with anorexia nervosa: experience of a defined interdisciplinary model of care MR Braude, D Con, D Clayton‐Chubb, R Nandurkar, LE Chua, ... Internal Medicine Journal 50 (1), 77-85, 2020 | 12 | 2020 |
| Interrater reliability of the assessment of disease activity by gastrointestinal ultrasound in a prospective cohort of patients with inflammatory bowel disease RL Smith, KM Taylor, AB Friedman, HY Su, D Con, PR Gibson European Journal of Gastroenterology & Hepatology 33 (10), 1280-1287, 2021 | 9 | 2021 |
| Liver disease prevalence and severity in people with serious mental illness: a cross-sectional analysis using non-invasive diagnostic tools MR Braude, D Con, J Lubel, A Bidwai, HT Nguyen, S Sharmamiglani, ... Hepatology International 15 (3), 812-820, 2021 | 8 | 2021 |
| Development of a simple, serum biomarker-based model predictive of the need for early biologic therapy in Crohn’s disease D Con, N Parthasarathy, M Bishara, RP Luber, N Joshi, A Wan, ... Journal of Crohn's and Colitis 15 (4), 583-593, 2021 | 8 | 2021 |
| Clinical trial: combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study) A Vasudevan, D Con, P De Cruz, MP Sparrow, AB Friedman, M Garg, ... Alimentary Pharmacology & Therapeutics 59 (4), 504-514, 2024 | 7 | 2024 |
| Split‐dose 1 L polyethylene glycol (PEG) with ascorbate is non‐inferior to split‐dose PEG with sodium picosulfate and magnesium citrate with similar tolerability: a randomized … K Nalankilli, DJ Gibson, S Anwar, D Con, H Chen, R Secomb, P Gibson, ... Jgh Open 5 (9), 1026-1032, 2021 | 7 | 2021 |
| Health care costs associated with Australian tertiary inflammatory bowel disease care B Jackson, D Con, R Ma, A Gorelik, D Liew, P De Cruz Scandinavian journal of gastroenterology 52 (8), 851-856, 2017 | 7 | 2017 |
| Mobile phone apps for inflammatory bowel disease self-management: a systematic assessment of content and tools. JMIR Mhealth Uhealth. 2016 Feb 01; 4 (1): e13. doi: 10.2196 … D Con, P De Cruz | 7 | |
Peter GibsonMonash university在 monash.edu 的电子邮件经过验证
